Shui On Leung
Chief Executive Officer at SINOMAB BIOSCIENCE LIMITED
Net worth: 31 M $ as of 2024-04-29
Shui On Leung active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SINOMAB BIOSCIENCE LIMITED | Chief Executive Officer | 2002-12-31 | - |
| Chairman | 2001-04-26 | - | |
| Founder | 2001-04-26 | - | |
| Hong Kong Genome Institute | Director/Board Member | - | - |
Career history of Shui On Leung
Former positions of Shui On Leung
| Companies | Position | Start | End |
|---|---|---|---|
| Novelmab Ltd. | Director/Board Member | 2011-08-31 | 2018-06-30 |
| The Hong Kong Institute of Biotechnology Ltd. | Chief Executive Officer | 2000-08-31 | 2003-07-31 |
| IMMUNOMEDICS, INC. | Corporate Officer/Principal | 1991-04-30 | 2000-06-30 |
Training of Shui On Leung
| University of Oxford | Doctorate Degree |
| The Chinese University of Hong Kong | Undergraduate Degree |
Statistics
International
| Hong Kong | 6 |
| United States | 2 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Chairman | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SINOMAB BIOSCIENCE LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
| The Hong Kong Institute of Biotechnology Ltd. | |
| Novelmab Ltd. | |
| Hong Kong Genome Institute |
- Stock Market
- Insiders
- Shui On Leung
- Experience
